SCHEMBL4897933

SCHEMBL4897933

Cc1ccc(S(=O)(=O)N(CCc2ccc(OCc3ccc(F)c(F)c3)cc2)Cc2ccc(F)c(F)c2)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 3/20 0.46
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
CA12 O43570 7/20 0.44
CA1 P00915 7/20 0.44
CA2 P00918 7/20 0.44
CA4 P22748 7/20 0.44
CA9 Q16790 7/20 0.44
CXCR3 P49682 3/20 0.42
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
CNR2 P34972 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
PPARA Q07869 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904285 0.91 TP53 (0.45) TAS2R14MAOAMAOBCA12CA1
SCHEMBL4908668 0.89 TAS2R14 (0.49) TAS2R14CA12CA1CA2CA4
SCHEMBL4906541 0.88 TAS2R14 (0.46) TAS2R14MAOBCA12CA1CA2
SCHEMBL4900641 0.87 MEN1 (0.54) TAS2R14CA12CA1CA2CA4
SCHEMBL4905775 0.87 TAS2R14 (0.58) TAS2R14CA12CA1CA2CA4
SCHEMBL4904466 0.87 CNR2 (0.53) TAS2R14CA12CA1CA2CA4
SCHEMBL4898092 0.86 TAS2R14 (0.48) TAS2R14CA12CA1CA2CA4
SCHEMBL4894471 0.85 CA12 (0.48) TAS2R14MAOBCA12CA1CA2
SCHEMBL4906456 0.82 TAS2R14 (0.43) TAS2R14CA12CA1CA2CA4
SCHEMBL4903420 0.81 LMNA (0.57) MAOAMAOBKMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TAS2R14 4032/4885MAOA 4248/4885MAOB 4263/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TAS2R14 4032/4885MAOA 4248/4885MAOB 4263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.